First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study

  1. García Alfonso, P.
  2. Valladares-Ayerbes, M.
  3. Muñoz Luengo, J.
  4. Pimentel, P.
  5. Viéitez, J.M.
  6. Cruz Hernandez, J.J.
  7. Llanos, M.
  8. Garcia Girón, C.
  9. Salud Salvia, A.
  10. Lloansí Vila, A.
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Year of publication: 2018

Volume: 29

Pages: viii183

Type: Article

DOI: 10.1093/ANNONC/MDY281.092 GOOGLE SCHOLAR lock_openOpen access editor